Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-45
SponsorNational University of Malaysia
About this trial
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus.
The main questions it aims to answer are:
* Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Eligibility criteria
Qualifiers
Singleton
Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus
Disqualifiers
autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
chronic kidney disease
fetal anomaly
women on steroid therapy
Trial design
Treatments tested in this trial
- Hydroxychloroquine Oral Tablet
Treatment groups
56 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Antenatal clinic, UKM Medical CentreRecruiting56000, Cheras, Kuala Lumpur
Malaysia
MalaysiaSponsors and collaborators
Source ClinicalTrials.gov